CytoSorbents Provides Preliminary Third Quarter Business Update and Revised 2021 Product Revenue Guidance
/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using...